Charles Hoeffer
Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle Proteins | 5 | 2026 | 244 | 2.550 |
Why?
| | Intracellular Signaling Peptides and Proteins | 6 | 2026 | 460 | 2.210 |
Why?
| | Long-Term Potentiation | 10 | 2017 | 200 | 1.800 |
Why?
| | Proto-Oncogene Proteins c-akt | 4 | 2025 | 437 | 1.790 |
Why?
| | Down Syndrome | 5 | 2026 | 534 | 1.580 |
Why?
| | Neuronal Plasticity | 12 | 2017 | 309 | 1.210 |
Why?
| | Brain | 6 | 2026 | 2941 | 1.150 |
Why?
| | Protein Biosynthesis | 5 | 2021 | 458 | 1.110 |
Why?
| | Astrocytes | 3 | 2025 | 224 | 1.080 |
Why?
| | Sleep | 3 | 2026 | 901 | 1.020 |
Why?
| | Hippocampus | 11 | 2017 | 967 | 0.960 |
Why?
| | Tauopathies | 4 | 2026 | 17 | 0.960 |
Why?
| | Behavior, Animal | 9 | 2023 | 520 | 0.960 |
Why?
| | Neurons | 11 | 2026 | 1642 | 0.950 |
Why?
| | Memory | 6 | 2021 | 296 | 0.940 |
Why?
| | Nicotinic Agonists | 2 | 2025 | 137 | 0.930 |
Why?
| | Nicotine | 2 | 2025 | 332 | 0.840 |
Why?
| | Calcium-Binding Proteins | 3 | 2022 | 220 | 0.830 |
Why?
| | Alzheimer Disease | 4 | 2022 | 622 | 0.820 |
Why?
| | Epistasis, Genetic | 2 | 2023 | 66 | 0.770 |
Why?
| | tau Proteins | 5 | 2026 | 115 | 0.730 |
Why?
| | Mice | 36 | 2026 | 18365 | 0.730 |
Why?
| | Chronobiology Disorders | 1 | 2022 | 16 | 0.730 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2023 | 99 | 0.720 |
Why?
| | Sleep Wake Disorders | 1 | 2026 | 302 | 0.720 |
Why?
| | DNA-Binding Proteins | 5 | 2023 | 1500 | 0.690 |
Why?
| | Animals | 46 | 2026 | 38109 | 0.670 |
Why?
| | Mice, Knockout | 17 | 2025 | 3125 | 0.660 |
Why?
| | Spatial Memory | 1 | 2020 | 28 | 0.660 |
Why?
| | Dendritic Spines | 2 | 2021 | 69 | 0.640 |
Why?
| | Anxiety | 6 | 2026 | 1110 | 0.630 |
Why?
| | Mice, Transgenic | 11 | 2026 | 2185 | 0.610 |
Why?
| | Extinction, Psychological | 1 | 2020 | 92 | 0.610 |
Why?
| | Mice, Inbred C57BL | 14 | 2026 | 5997 | 0.600 |
Why?
| | Interleukin-17 | 2 | 2017 | 118 | 0.600 |
Why?
| | Synapses | 9 | 2017 | 439 | 0.590 |
Why?
| | Signal Transduction | 11 | 2016 | 5233 | 0.570 |
Why?
| | Aging | 2 | 2022 | 1966 | 0.550 |
Why?
| | TOR Serine-Threonine Kinases | 6 | 2014 | 451 | 0.550 |
Why?
| | Disease Models, Animal | 14 | 2026 | 4569 | 0.520 |
Why?
| | Basolateral Nuclear Complex | 1 | 2017 | 11 | 0.510 |
Why?
| | Eukaryotic Initiation Factor-4E | 2 | 2021 | 32 | 0.510 |
Why?
| | Memory, Long-Term | 2 | 2020 | 12 | 0.510 |
Why?
| | Memory Consolidation | 1 | 2017 | 14 | 0.500 |
Why?
| | Transcriptome | 1 | 2023 | 1046 | 0.490 |
Why?
| | Fragile X Syndrome | 3 | 2012 | 119 | 0.480 |
Why?
| | Nerve Degeneration | 1 | 2015 | 48 | 0.460 |
Why?
| | Genome-Wide Association Study | 4 | 2023 | 1407 | 0.450 |
Why?
| | Autism Spectrum Disorder | 2 | 2017 | 412 | 0.430 |
Why?
| | Up-Regulation | 2 | 2021 | 852 | 0.420 |
Why?
| | Protein Synthesis Inhibitors | 2 | 2012 | 48 | 0.420 |
Why?
| | Gene Expression Regulation | 6 | 2017 | 2609 | 0.420 |
Why?
| | Interneurons | 2 | 2026 | 128 | 0.420 |
Why?
| | Sensory Gating | 2 | 2013 | 44 | 0.400 |
Why?
| | Fluoxetine | 1 | 2013 | 54 | 0.390 |
Why?
| | GABAergic Neurons | 1 | 2013 | 35 | 0.380 |
Why?
| | Eukaryotic Initiation Factor-4F | 1 | 2012 | 4 | 0.380 |
Why?
| | Gene Expression | 1 | 2017 | 1490 | 0.370 |
Why?
| | Protein Phosphatase 1 | 2 | 2013 | 32 | 0.370 |
Why?
| | Receptors, Nicotinic | 3 | 2025 | 323 | 0.350 |
Why?
| | Mental Disorders | 1 | 2020 | 1172 | 0.340 |
Why?
| | Eukaryotic Initiation Factor-4G | 1 | 2011 | 6 | 0.340 |
Why?
| | Mitochondria | 2 | 2015 | 984 | 0.340 |
Why?
| | Corticosterone | 1 | 2012 | 244 | 0.330 |
Why?
| | eIF-2 Kinase | 2 | 2024 | 29 | 0.320 |
Why?
| | Phosphorylation | 10 | 2026 | 1733 | 0.310 |
Why?
| | Wakefulness | 2 | 2024 | 169 | 0.310 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2012 | 428 | 0.300 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2008 | 10 | 0.290 |
Why?
| | Raptors | 1 | 2008 | 5 | 0.290 |
Why?
| | Motor Activity | 3 | 2022 | 722 | 0.290 |
Why?
| | Male | 23 | 2026 | 72406 | 0.290 |
Why?
| | Feces | 1 | 2012 | 513 | 0.280 |
Why?
| | Maze Learning | 5 | 2014 | 104 | 0.270 |
Why?
| | Protein Isoforms | 2 | 2020 | 402 | 0.270 |
Why?
| | Receptors, Metabotropic Glutamate | 4 | 2014 | 37 | 0.260 |
Why?
| | Protein Kinases | 2 | 2008 | 315 | 0.260 |
Why?
| | Circadian Rhythm | 1 | 2012 | 514 | 0.260 |
Why?
| | Receptors, AMPA | 3 | 2026 | 147 | 0.250 |
Why?
| | Memory Disorders | 3 | 2015 | 194 | 0.250 |
Why?
| | Fear | 3 | 2008 | 366 | 0.250 |
Why?
| | Nervous System Diseases | 1 | 2009 | 284 | 0.250 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2023 | 2147 | 0.240 |
Why?
| | RNA, Messenger | 4 | 2017 | 2832 | 0.240 |
Why?
| | Analysis of Variance | 4 | 2017 | 1311 | 0.240 |
Why?
| | KCNQ2 Potassium Channel | 1 | 2025 | 15 | 0.230 |
Why?
| | 4-Aminopyridine | 1 | 2025 | 30 | 0.230 |
Why?
| | Potassium Channel Blockers | 1 | 2025 | 47 | 0.230 |
Why?
| | Electroencephalography | 2 | 2026 | 551 | 0.230 |
Why?
| | Protein Aggregation, Pathological | 1 | 2025 | 22 | 0.230 |
Why?
| | Neocortex | 1 | 2025 | 49 | 0.220 |
Why?
| | Phenotype | 5 | 2023 | 3164 | 0.220 |
Why?
| | Hydrazones | 2 | 2017 | 26 | 0.220 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 125 | 0.220 |
Why?
| | Anti-Anxiety Agents | 2 | 2023 | 45 | 0.220 |
Why?
| | In Vitro Techniques | 7 | 2014 | 1048 | 0.210 |
Why?
| | Nucleus Accumbens | 1 | 2026 | 135 | 0.210 |
Why?
| | Thiazoles | 2 | 2017 | 136 | 0.210 |
Why?
| | Drosophila melanogaster | 2 | 2003 | 236 | 0.210 |
Why?
| | Cyclic GMP-Dependent Protein Kinase Type II | 2 | 2014 | 2 | 0.200 |
Why?
| | Coculture Techniques | 1 | 2024 | 246 | 0.200 |
Why?
| | Diazepam | 1 | 2023 | 33 | 0.200 |
Why?
| | Mutation | 3 | 2016 | 4099 | 0.200 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 3 | 2013 | 145 | 0.200 |
Why?
| | Gliosis | 1 | 2023 | 29 | 0.200 |
Why?
| | RNA, Double-Stranded | 1 | 2023 | 56 | 0.190 |
Why?
| | Cells, Cultured | 4 | 2025 | 4155 | 0.190 |
Why?
| | Vesicular Transport Proteins | 1 | 2003 | 86 | 0.190 |
Why?
| | Nerve Net | 1 | 2025 | 285 | 0.190 |
Why?
| | Rats, Sprague-Dawley | 4 | 2021 | 2540 | 0.180 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2022 | 19 | 0.180 |
Why?
| | Long-Term Synaptic Depression | 3 | 2014 | 51 | 0.180 |
Why?
| | Sleep Deprivation | 1 | 2024 | 206 | 0.180 |
Why?
| | Pyramidal Cells | 2 | 2025 | 79 | 0.180 |
Why?
| | Neural Inhibition | 2 | 2017 | 178 | 0.180 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 328 | 0.170 |
Why?
| | Multifactorial Inheritance | 1 | 2023 | 203 | 0.170 |
Why?
| | Nerve Tissue Proteins | 3 | 2024 | 592 | 0.170 |
Why?
| | Cerebral Cortex | 2 | 2016 | 465 | 0.170 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 276 | 0.170 |
Why?
| | Spatial Behavior | 1 | 2020 | 24 | 0.170 |
Why?
| | Epilepsy | 1 | 2025 | 387 | 0.170 |
Why?
| | Motor Neurons | 1 | 2023 | 234 | 0.160 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 320 | 0.160 |
Why?
| | Spinal Cord | 1 | 2023 | 382 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 151 | 0.160 |
Why?
| | Calcineurin | 2 | 2013 | 105 | 0.160 |
Why?
| | Female | 12 | 2026 | 78376 | 0.160 |
Why?
| | Cell Nucleus | 1 | 2003 | 619 | 0.160 |
Why?
| | Anxiety Disorders | 1 | 2023 | 373 | 0.150 |
Why?
| | Calcium | 1 | 2026 | 1184 | 0.150 |
Why?
| | Synaptic Transmission | 2 | 2014 | 290 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2020 | 88 | 0.150 |
Why?
| | Genetic Markers | 1 | 2020 | 331 | 0.150 |
Why?
| | Rats | 4 | 2021 | 5614 | 0.150 |
Why?
| | Amygdala | 2 | 2011 | 198 | 0.150 |
Why?
| | Memory, Short-Term | 2 | 2014 | 271 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2022 | 367 | 0.130 |
Why?
| | Electrocorticography | 1 | 2018 | 20 | 0.130 |
Why?
| | Conditioning, Classical | 2 | 2017 | 120 | 0.130 |
Why?
| | Brain Waves | 1 | 2018 | 45 | 0.130 |
Why?
| | Polyribosomes | 1 | 2017 | 22 | 0.130 |
Why?
| | Models, Animal | 2 | 2017 | 392 | 0.130 |
Why?
| | Models, Biological | 3 | 2009 | 1822 | 0.120 |
Why?
| | Neurofibrillary Tangles | 1 | 2016 | 13 | 0.120 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 157 | 0.120 |
Why?
| | Association Learning | 1 | 2017 | 71 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2024 | 2050 | 0.120 |
Why?
| | CA1 Region, Hippocampal | 2 | 2014 | 51 | 0.120 |
Why?
| | Humans | 20 | 2026 | 144957 | 0.120 |
Why?
| | Transcription Factors | 2 | 2022 | 1742 | 0.120 |
Why?
| | Dynamins | 1 | 2015 | 36 | 0.120 |
Why?
| | Haloperidol | 2 | 2014 | 33 | 0.110 |
Why?
| | Sex Characteristics | 1 | 2020 | 791 | 0.110 |
Why?
| | Antipsychotic Agents | 2 | 2014 | 214 | 0.110 |
Why?
| | Th17 Cells | 1 | 2016 | 101 | 0.110 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 169 | 0.110 |
Why?
| | Alcoholism | 1 | 2021 | 817 | 0.110 |
Why?
| | Electric Stimulation | 3 | 2014 | 276 | 0.110 |
Why?
| | Neuroimaging | 1 | 2017 | 292 | 0.110 |
Why?
| | Social Behavior | 1 | 2017 | 288 | 0.100 |
Why?
| | Cell Count | 2 | 2013 | 321 | 0.100 |
Why?
| | Antibodies | 1 | 2016 | 403 | 0.100 |
Why?
| | Pyridines | 3 | 2013 | 605 | 0.100 |
Why?
| | GABA-A Receptor Agonists | 1 | 2013 | 17 | 0.100 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2011 | 117 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1472 | 0.100 |
Why?
| | Sterols | 1 | 2012 | 21 | 0.090 |
Why?
| | Nitro Compounds | 1 | 2012 | 8 | 0.090 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2014 | 193 | 0.090 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2013 | 148 | 0.090 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 172 | 0.090 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 781 | 0.090 |
Why?
| | Gene Deletion | 1 | 2013 | 389 | 0.090 |
Why?
| | Photoperiod | 1 | 2012 | 55 | 0.090 |
Why?
| | Ribosomal Protein S6 | 1 | 2011 | 18 | 0.090 |
Why?
| | Reaction Time | 1 | 2013 | 438 | 0.090 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2011 | 9 | 0.090 |
Why?
| | Dopamine | 1 | 2014 | 289 | 0.090 |
Why?
| | Motor Skills | 1 | 2012 | 104 | 0.090 |
Why?
| | Amyloid beta-Peptides | 2 | 2011 | 241 | 0.090 |
Why?
| | Sirolimus | 2 | 2011 | 281 | 0.090 |
Why?
| | Primary Cell Culture | 1 | 2012 | 174 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2008 | 36 | 0.080 |
Why?
| | Oxidants | 1 | 2011 | 103 | 0.080 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 125 | 0.080 |
Why?
| | Genotype | 2 | 2014 | 1835 | 0.080 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2014 | 196 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1786 | 0.080 |
Why?
| | Superoxides | 1 | 2011 | 204 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2016 | 675 | 0.070 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 826 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2015 | 1339 | 0.070 |
Why?
| | Exploratory Behavior | 1 | 2008 | 86 | 0.070 |
Why?
| | Peptide Elongation Factor 1 | 1 | 2008 | 10 | 0.070 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 25 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2014 | 1167 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 140 | 0.070 |
Why?
| | Activating Transcription Factor 4 | 1 | 2007 | 22 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2007 | 319 | 0.060 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 33 | 0.060 |
Why?
| | Space Perception | 1 | 2008 | 83 | 0.060 |
Why?
| | Pregnancy | 2 | 2017 | 7191 | 0.060 |
Why?
| | Eukaryotic Initiation Factors | 2 | 2021 | 12 | 0.060 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2006 | 48 | 0.060 |
Why?
| | Neuromuscular Junction | 2 | 2003 | 65 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2114 | 0.060 |
Why?
| | Pair Bond | 1 | 2026 | 20 | 0.060 |
Why?
| | Larva | 2 | 2003 | 242 | 0.060 |
Why?
| | Purkinje Cells | 1 | 2026 | 64 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2017 | 6434 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2003 | 292 | 0.050 |
Why?
| | Cohort Studies | 1 | 2015 | 5965 | 0.050 |
Why?
| | Protein Binding | 1 | 2011 | 2276 | 0.050 |
Why?
| | Sleep, REM | 1 | 2024 | 44 | 0.050 |
Why?
| | Drosophila | 1 | 2025 | 166 | 0.050 |
Why?
| | Protein Domains | 1 | 2026 | 313 | 0.050 |
Why?
| | Electrodes | 1 | 2024 | 115 | 0.050 |
Why?
| | Carrier Proteins | 2 | 2010 | 737 | 0.050 |
Why?
| | Time Factors | 2 | 2012 | 7183 | 0.050 |
Why?
| | N-Ethylmaleimide-Sensitive Proteins | 1 | 2003 | 5 | 0.050 |
Why?
| | Calcium-Transporting ATPases | 1 | 2003 | 33 | 0.050 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2003 | 33 | 0.050 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2003 | 38 | 0.050 |
Why?
| | Learning | 1 | 2008 | 452 | 0.050 |
Why?
| | Body Temperature | 1 | 2024 | 229 | 0.050 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2003 | 42 | 0.050 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2003 | 121 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 128 | 0.050 |
Why?
| | Blood-Brain Barrier | 1 | 2024 | 155 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2023 | 397 | 0.050 |
Why?
| | Paralysis | 1 | 2003 | 67 | 0.050 |
Why?
| | Methoxyhydroxyphenylglycol | 2 | 2014 | 13 | 0.050 |
Why?
| | Action Potentials | 1 | 2025 | 507 | 0.050 |
Why?
| | Species Specificity | 1 | 2023 | 574 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2002 | 79 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2003 | 212 | 0.040 |
Why?
| | Psychopathology | 1 | 2021 | 56 | 0.040 |
Why?
| | Adult | 2 | 2017 | 40506 | 0.040 |
Why?
| | Central Nervous System | 1 | 2003 | 281 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 863 | 0.040 |
Why?
| | Bombyx | 1 | 2000 | 7 | 0.040 |
Why?
| | Temperature | 1 | 2003 | 679 | 0.040 |
Why?
| | Apolipoproteins | 1 | 2000 | 38 | 0.040 |
Why?
| | Ultrasonography | 1 | 2003 | 770 | 0.040 |
Why?
| | Seizures | 1 | 2003 | 477 | 0.040 |
Why?
| | NADPH Oxidase 2 | 2 | 2011 | 35 | 0.040 |
Why?
| | Child | 2 | 2025 | 22657 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 551 | 0.030 |
Why?
| | NADPH Oxidases | 2 | 2011 | 124 | 0.030 |
Why?
| | Prepulse Inhibition | 1 | 2017 | 12 | 0.030 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2017 | 35 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2002 | 906 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2010 | 381 | 0.030 |
Why?
| | Child, Preschool | 1 | 2012 | 11799 | 0.030 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 93 | 0.030 |
Why?
| | Reflex, Startle | 1 | 2017 | 76 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2011 | 496 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2016 | 14 | 0.030 |
Why?
| | Antibodies, Blocking | 1 | 2016 | 37 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2017 | 370 | 0.030 |
Why?
| | Receptors, Retinoic Acid | 1 | 2016 | 42 | 0.030 |
Why?
| | Behavioral Symptoms | 1 | 2016 | 43 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2017 | 170 | 0.030 |
Why?
| | Young Adult | 1 | 2012 | 14126 | 0.030 |
Why?
| | Tobacco Use Disorder | 1 | 2017 | 218 | 0.030 |
Why?
| | Electrical Synapses | 1 | 2014 | 11 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2021 | 826 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2014 | 68 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 139 | 0.020 |
Why?
| | Rotarod Performance Test | 1 | 2012 | 15 | 0.020 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 196 | 0.020 |
Why?
| | Post-Synaptic Density | 1 | 2012 | 12 | 0.020 |
Why?
| | Schizophrenia | 1 | 2017 | 446 | 0.020 |
Why?
| | Cyclic GMP | 1 | 2012 | 92 | 0.020 |
Why?
| | Adolescent | 1 | 2012 | 22453 | 0.020 |
Why?
| | Aged | 1 | 2012 | 25947 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2011 | 61 | 0.020 |
Why?
| | Emetine | 1 | 2011 | 7 | 0.020 |
Why?
| | Onium Compounds | 1 | 2011 | 8 | 0.020 |
Why?
| | Bicuculline | 1 | 2011 | 18 | 0.020 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2011 | 19 | 0.020 |
Why?
| | rap GTP-Binding Proteins | 1 | 2011 | 9 | 0.020 |
Why?
| | Ubiquinone | 1 | 2011 | 35 | 0.020 |
Why?
| | Electrophysiological Phenomena | 1 | 2011 | 60 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2011 | 108 | 0.020 |
Why?
| | Biphenyl Compounds | 1 | 2011 | 68 | 0.020 |
Why?
| | Isoproterenol | 1 | 2011 | 97 | 0.020 |
Why?
| | Adrenergic beta-Agonists | 1 | 2011 | 93 | 0.020 |
Why?
| | Biophysics | 1 | 2011 | 74 | 0.020 |
Why?
| | Flavonoids | 1 | 2011 | 87 | 0.020 |
Why?
| | Organophosphorus Compounds | 1 | 2011 | 85 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4A | 1 | 2010 | 6 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2011 | 289 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2010 | 22 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4564 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2011 | 768 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 151 | 0.020 |
Why?
| | Middle Aged | 1 | 2012 | 35928 | 0.020 |
Why?
| | Serine | 1 | 2010 | 145 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 301 | 0.020 |
Why?
| | RNA 5' Terminal Oligopyrimidine Sequence | 1 | 2008 | 1 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 621 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2010 | 211 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2010 | 346 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 549 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 173 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 2032 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2010 | 699 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 847 | 0.010 |
Why?
| | Conditioning, Operant | 1 | 2006 | 99 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2010 | 629 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2010 | 538 | 0.010 |
Why?
| | Taste | 1 | 2008 | 240 | 0.010 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 228 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2002 | 55 | 0.010 |
Why?
| | Dimerization | 1 | 2002 | 194 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 153 | 0.010 |
Why?
| | Electrophysiology | 1 | 2002 | 218 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2002 | 209 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2002 | 196 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 277 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2002 | 1258 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2000 | 2157 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2000 | 2931 | 0.010 |
Why?
|
|
Hoeffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|